Validation of the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) for Parkinson's Disease
Description: The US Food and Drug (FDA) requires acceptable outcome measures to approve a cognitive-enhancing medication for the treatment of mild cognitive impairment (MCI) in Parkinson's disease (PD). The FDA has indicated that the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) is an acceptable combined cognitive-functional outcome for use in clinical trials; however, the CDR-SOB has not yet been validated for use in PD. This project will assess the validity of the CDR-SOB by comparing the scale to expert diagnosis in a cohort of 100 participants with PD at the University of Pennsylvania (UPenn).
Funding type: research
Funder scheme: Research Grant
Start date: 2017-01-01
End date: 2017-12-31
Investigator: Daniel Weintraub (lead)
Institutions: University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: mjff-validation-clinical-dementia-rating-scale-sum-boxes-cdr-sob-parkinsons-disease
OpenAlex ID: G4558370132
